Religare Housing Development Finance Corporation Limited (RHDFCL), a step down subsidiary of Religare Enterprises Limited ...

Rivian and VW struck a $5 billion deal last year to form a joint venture to develop next-generation EV technology.

The complete Condensed Consolidated Interim (Unaudited) Financial Statements and Notes and Management's Discussion & Analysis ...

ATH-1105 is the Company's novel, orally available, brain-penetrant, next-generation small molecule drug candidate designed to ...

Initial Group and Untitled Entertainment have hired former UTA Corporate Communications Manager Matt Leonard as Vice ...

Terna is accelerating its CapEx, notably on €23B 2024–2028 industrial plan. Read why I believe a more appropriate rating is ...

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, ...

Solana (SOL) price surged past $184 on Wednesday, marking a 25% gain in May. The rally follows a fresh capital injection by ...

Since 2017, Urban Confluence executive director Steve Borkenhagen has touted a plan to create a landmark in the city's downtown core to draw visitors and tourists. The nonprofit's leaders likened the ...

Law firm Freeths has appointed partner James Dean in Bristol to lead the growth and development of the national pensions ...

Adults with peanut allergy tolerated and adhered to treatment with a toothpaste that provided oral mucosal immunotherapy, according to a study published in Annals of Allergy, Asthma & Immunology.

Mike Moses — who earned a Florida Tech master’s degree in space sciences in 1991 — delivered a spring commencement speech on ...